The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrence-Reference-Cited by-同舟云学术

The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrence

Published:2013-05-07 Issue:9 Volume:15 Page:1151-1159
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Shibahara Ichiyo,Sonoda Yukihiko,Saito Ryuta,Kanamori Masayuki,Yamashita Yoji,Kumabe Toshihiro,Watanabe Mika,Suzuki Hiroyoshi,Watanabe Takashi,Ishioka Chikashi,Tominaga Teiji

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/15/9/1151/16860071/not066.pdf

Reference42 articles.

1. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network;Weller;J Clin Oncol.,2009

2. IDH1 and IDH2 mutations in gliomas;Yan;N Engl J Med.,2009

3. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial;Stummer;Lancet Oncol.,2006

4. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial;Senft;Lancet Oncol.,2011

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted delivery of nanomedicines to glioblastoma: Overcoming the clinical barrier;Journal of Drug Delivery Science and Technology;2024-09

2. Clinical and molecular features of patients with IDH1 wild-type primary glioblastoma presenting unexpected short-term survival after gross total resection;Journal of Neuro-Oncology;2024-06-05

3. Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease;Cellular & Molecular Biology Letters;2024-03-26

4. Multimodal MRI lesion habitat-based radiomics analysis for preoperative prediction of spatial pattern in locally recurrent high-grade gliomas;2024-01-19

5. Optimizing CAR-T Therapy for Glioblastoma;Molecular Diagnosis & Therapy;2023-09-12